Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry (v3.7.0) was added to the Record History and the previous revision (v3.6.6) was removed, updating the listing of the study record versions.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.6.6) appears in the study's record history, reflecting a metadata update to the record. This update does not alter the study data or the information presented to users.SummaryDifference0.1%

- Check75 days agoChange DetectedThe history now shows a new revision labeled v3.6.5, replacing the previous v3.6.4. This indicates an internal update to the page version rather than changes to the study details.SummaryDifference0.1%

- Check89 days agoChange DetectedThe record history now shows the latest revision as v3.6.4, replacing the previous v3.6.3 entry. This reflects an update to the study record version.SummaryDifference0.1%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.